Stoke Therapeutics Inc.

NASDAQ: STOK
Share price (1/8/25): $8.96
Market cap (1/8/25): $475 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Automatic shelf registration

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Ownership Filter

Kaye Edward M. MD

Ezbon International Ltd, Blue Horizon Enterprise Ltd, Montrago Trustees Ltd, Skorpios Trust

Blue Horizon Enterprise Ltd

News Filter

Announces Alignment With Global Regulatory Agencies and Plans to Initiate a Phase 3 Study of Zorevunersen as Potentially the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome

Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome

Reports Third Quarter Financial Results and Provides Business Updates

In the Court of Chancery of the State of Delaware

Reports Second Quarter Financial Results and Provides Business Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Correspondence with the SEC